During the past decade, Ewha Womans University Medical Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ewha Womans University Medical Center" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Ewha Womans University" with 4 trials sponsored, "Inha University Hospital" with 3 trials sponsored, "SK Bioscience Co., Ltd." with 3 trials sponsored and "Chong Kun Dang Pharmaceutical" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ewha Womans University Medical Center" #1 collaborator was "Coalition for Epidemic Preparedness Innovations" with 3 trials as a collaborator, "Chung-Ang University Hosptial, Chung-Ang University College of Medicine" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Hallym University Medical Center" with 2 trials as a collaborator and "Inje University" with 2 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Ewha Womans University Medical Center" are "Hypertension" (4 trials), "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (3 trials), "Gastric Cancer" (3 trials) and "Asthma" (2 trials). Many other conditions were trialed in "Ewha Womans University Medical Center" in a lesser frequency.

Most popular intervention types in "Ewha Womans University Medical Center" are "Drug" (29 trials), "Procedure" (5 trials), "Biological" (4 trials), "Device" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Gantenerumab" (4 trials), "Multidomain intervention" (2 trials), "Normal saline (0.9% sodium chloride solution) - Stage 1" (2 trials) and "Normal saline (0.9% sodium chloride solution)- Stage 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ewha Womans University Medical Center" are 42 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ewha Womans University Medical Center". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Ewha Womans University Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ewha Womans University Medical Center, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 10 trials that are defined as “Not Applicable".